Berek P, Kopolovets I, Sihotský V, Virág M, Dzsinich C, Frankovičová M
Rozhl Chir. 2020 Spring;99(4):167-171. doi: 10.33699/PIS.2020.99.4.167-171.
Thrombosis of inferior vena cava (IVC) is an important complication amongst oncological patients. Tumor thrombus of IVC is characteristic for patients with renal cell carcinoma, occurring in 1018%. The aim of the work is to analyze of surgical treatment in patients with cancer thrombosis of inferior vena cava in kidney cancer.
Between 2010 and 2019 we treated 32 patients with kidney cancer complicated by thrombotic infiltration of the inferior vena cava. According to Nesbitt classification the levels of thrombotic infiltration of the inferior vena cava were: I-8 (25%), II-14 (43.8%), III-6 (18.8%), and IV-4 (12.5%). Nephrectomy with thrombectomy of the cancer thrombus in the inferior vena cava was performed in all patients. In addition to laparotomy, sternotomy was approached in 4 patients with Nesbitt IV and in 2 patients with Nesbitt III.
Primary suture of IVC was performed in 26 patients; angioplasty of IVC was performed in 4 patients; and resection of IVC with replacement using a polytetrafluoroethylene interposition graft was done in 2 patients. Radical surgical treatment was performed in 27 (84.3%) patients, and palliative in 5 (15.6%) patients. In the postoperative period, 1 (3.1%) patient (Nesbitt IV) died of cardiac failure during hospitalisation. Two-year survival was observed in 75% of the cases.
Tumorous infiltration of IVC is associated with a high potential for tumour embolisation to the lungs, leading to the formation of multiple metastases and spreading of the underlying disease. Postoperative comfort is improved considerably after nephrectomy of the affected kidney and removal of the tumour thrombus, including IVC resection as appropriate, and when combined with oncological treatment, the survival rate is increased significantly, as well.
下腔静脉血栓形成是肿瘤患者的一种重要并发症。下腔静脉肿瘤血栓是肾细胞癌患者的特征性表现,发生率为10% - 18%。本研究的目的是分析肾癌合并下腔静脉癌栓患者的手术治疗情况。
2010年至2019年期间,我们治疗了32例肾癌合并下腔静脉血栓浸润的患者。根据Nesbitt分类,下腔静脉血栓浸润的程度为:I级 - 8例(25%),II级 - 14例(43.8%),III级 - 6例(18.8%),IV级 - 4例(12.5%)。所有患者均行肾癌根治术并切除下腔静脉内的癌栓。除剖腹手术外,4例Nesbitt IV级和2例Nesbitt III级患者采用了胸骨切开术。
26例患者行下腔静脉一期缝合;4例患者行下腔静脉血管成形术;2例患者行下腔静脉切除并使用聚四氟乙烯移植片置换。27例(84.3%)患者接受了根治性手术治疗,5例(15.6%)患者接受了姑息性手术治疗。术后,1例(3.1%)患者(Nesbitt IV级)在住院期间死于心力衰竭。75%的患者观察到两年生存率。
下腔静脉肿瘤浸润与肿瘤肺栓塞的高风险相关,可导致多发性转移和基础疾病的扩散。切除患肾及肿瘤血栓,包括必要时切除下腔静脉,术后舒适度可显著改善,与肿瘤治疗相结合时,生存率也可显著提高。